Desmopressin, a drug that limits the amount of water that is eliminated in the urine and also is used to prevent and control excessive thirst, urination and dehydration due to injury, surgery and certain medical conditions has received a U.S. Food and Drug warning update request.
The FDA has requested that the manufactures of desmopressin update the prescribing information to include new information about severe hyponatremia, dangerously low levels of sodium in the body, and seizures. Children treated with desmopressin nasal spray for primary nocturnal enuresis (PNE/ bed wetting) are particularly susceptible and the drug is no longer indicated for the treatment of PNE.
According to the FDA 61 reports of seizures, 36 associated with the nasal spray form of the drug were reported. There were also reports of two deaths though the FDA said it was not clear whether the drug caused the reported deaths.
[Source: FDA]
We came across your blog posting, and would like to advise that drugs do not address the root cause of bedwetting: A deep sleep disorder. If pills and nasal sprays are being used and show some effectiveness, once the drugs are discontinued, the bedwetting will resume. They are merely a temporary fix, and have many side effects. For 32 years, the Enuresis Treatment Center has successfully treated thousands of people from around the world by establishing a new and healthy pattern of sleep. The Enuresis Treatment Center cures bedwetting without the use of drugs. Physicians bring their own children for treatment instead of subjecting them to drugs. The Enuresis Treatment Center has put together an informative guide to understanding and treating bedwetting. This free bedwetting guide is available to download at www.freebedwettingguide.com.
Posted by: Enuresis Treatment Center | December 12, 2007 2:17 PM | Permalink to Comment